trending Market Intelligence /marketintelligence/en/news-insights/trending/3gHsHPQtAuQpgHaUFf_jtA2 content esgSubNav
In This List

Israel's Taro completes $250M share buyback program

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Israel's Taro completes $250M share buyback program

Taro Pharmaceutical Industries Ltd. completed a $250 million share buyback program which was announced in November 2016.

The Israeli pharmaceutical company bought back 2,493,378 ordinary shares at an average price of $100.28 per share.